Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rBV A/B-40 vaccine in healthy adults
NCT00764634Phase 2Completed
- Sponsor
- DynPort Vaccine Company
- Start
- Sep 2008
- Primary completion
- Mar 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant botulinum vaccine A/B in botulism, sponsored by DynPort Vaccine Company. Started Sep 2008; status: completed.
02
Drugs
recombinant botulinum vaccine A/B
03
Conditions
botulism
Beyond the preview
Go deeper on NCT00764634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00764634.